These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 4722571

  • 1. L-dopa level in plasma, primary condition for the kinetic effect.
    Birkmayer W, Danielcyk W, Neumayer E, Riederer P.
    J Neural Transm; 1973; 34(2):133-43. PubMed ID: 4722571
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Ro 4-4602 and levodopa in the treatment of Parkinsonism.
    Miller EM, Wiener L.
    Neurology; 1974 May; 24(5):482-6. PubMed ID: 4857107
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of Parkinson's disease with L-DOPA and an association L-DOPA plus a DOPA decarboxylase inhibitor.
    Fazio C, Agnoli A, Casacchia M, Reitano M, Ruggieri S, Barba C, Volante F.
    Z Neurol; 1972 May; 202(4):347-55. PubMed ID: 4117654
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of Parkinsonism with a combination of levodopa and the decarboxylase inhibitor and RO 46-4602 (a comparison with levodopa treatment alone).
    Dupont E, Hansen E, Melsens S, Parkenberg H, Holm P.
    Acta Neurol Scand Suppl; 1972 May; 51():115-7. PubMed ID: 4514334
    [No Abstract] [Full Text] [Related]

  • 8. A year's comparison of treatment of patients with parkinson's disease with levodopa combined with carbidopa versus treatment with levodopa alone.
    Marsden CD, Parkes JD, Rees JE.
    Lancet; 1973 Dec 29; 2(7844):1459-62. PubMed ID: 4129310
    [No Abstract] [Full Text] [Related]

  • 9. Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486).
    Yahr MD, Duvoisin RC, Mendoza MR, Schear MJ, Barrett RE.
    Trans Am Neurol Assoc; 1971 Dec 29; 96():55-8. PubMed ID: 5159129
    [No Abstract] [Full Text] [Related]

  • 10. [Parkinsonism and plasma metabolism of dihydroxyphenylalanine administered with an inhibitor of decarboxylase].
    Geissbühler F, Constantinidis J, Eisenring JJ, Krassoievitch M, Yanniotis G, Tissot R.
    Clin Chim Acta; 1971 Jun 29; 33(1):111-5. PubMed ID: 5097993
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Modification of levodopa effect by systemic decarboxylase inhibition.
    Mars H.
    Arch Neurol; 1973 Feb 29; 28(2):91-5. PubMed ID: 4683155
    [No Abstract] [Full Text] [Related]

  • 13. Failure of vitamin B6 to reverse the L-dopa effect in patients on a dopa decarboxylase inhibitor.
    Klawans HL, Ringel SP, Shenker DM.
    J Neurol Neurosurg Psychiatry; 1971 Dec 29; 34(6):682-6. PubMed ID: 5158783
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Plasma testosterone content of male patients with Parkinson's disease during L-dopa treatment with or without dopadecarboxylase inhibitor.
    Pekkarinen A, Rinne UK, Salokangas R, Siirtola T, Sonninen V.
    Acta Neurol Scand Suppl; 1972 Dec 29; 51():129-30. PubMed ID: 4514339
    [No Abstract] [Full Text] [Related]

  • 16. Effect of L-dopa on plasma free fatty acids and plasma glucose.
    Rivera-Calimlim L, Bianchine JR.
    Metabolism; 1972 Jul 29; 21(7):611-7. PubMed ID: 5040916
    [No Abstract] [Full Text] [Related]

  • 17. Levodopa and pressor amine sensitivity in parkinsonism.
    Reid JL, Calne DB, George CF, Vakil SD.
    Clin Pharmacol Ther; 1972 Jul 29; 13(3):400-6. PubMed ID: 5026378
    [No Abstract] [Full Text] [Related]

  • 18. [Potentiation of L-Dopa in parkinsonism by means of an inhibitor of peripheral decarboxylation].
    Court J, Kase JC, Mena I, Palacios E.
    Rev Med Chil; 1973 Jun 29; 101(6):452-5. PubMed ID: 4764560
    [No Abstract] [Full Text] [Related]

  • 19. Plasma concentration of levodopa in patients with Parkinson's disease.
    Rinne UK, Sonninen V, Siirtola T.
    Eur Neurol; 1973 Jun 29; 10(5):301-10. PubMed ID: 4789106
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.